NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has signed an in-network provider agreement with Blue Cross Blue Shield (BCBS) of Minnesota to provide access to its cancer diagnostics and genomic testing services to the healthcare network's 2.6 million members.

BCBS Minnesota is the largest health plan in the state, the company said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.